Hang Chu

This inventor holds 18 USPTO granted patents and 12 published patent applications and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Gilead Sciences, Inc., Terremoto Biosciences, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hang Chu. Retrieved from https://idiyas.com/inventor/hang-chu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 12)

% Patents Active = 100.0

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 13.1

ph-index = 6

Forward Citations = 68(Granted Patents)

Location History:

San Mateo, CA (US) (2020 - 2024)
Foster City, CA (US) (2024)

Company Filing History:

16 out of 946

Gilead Sciences, Inc.

patents

2 out of 2

Terremoto Biosciences, Inc.

patents

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

AKT1 Modifiers

MCL1 Inhibitors

Bridged Tricyclic Compounds

Covalent Modifiers

Therapeutic Compounds

HIV Virus Treatment

Pyridotriazine Compounds

Pharmaceutical Use

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624034 - Non-covalent modifiers of AKT1 and uses thereof (2026-05-12),

2. 12570655 - CYSTEINE COVALENT MODIFIERS OF AKT1 AND USES THEREOF (2026-03-10),

3. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2025-09-23),

4. 12404262 - Therapeutic compounds for HIV virus infection (2025-09-02),

5. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2025-02-18),

6. 12202842 - MCL1 inhibitors (2025-01-21),

7. 12187734 - Substituted pyridotriazine compounds and uses thereof (2025-01-07),

8. 12162844 - MCL-1 inhibitors (2024-12-10),

9. 12054496 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2024-08-06),

10. 12024528 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2024-07-02),

11. 11897892 - Substituted pyridotriazine compounds and uses thereof (2024-02-13),

12. 11667652 - MCL1 inhibitors (2023-06-06),

13. 11643400 - MCL-1 inhibitors (2023-05-09),

14. 11613546 - Substituted pyridotriazine compounds and uses thereof (2023-03-28),

15. 11548902 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2023-01-10),

Title: Inventor Hang Chu - Revolutionizing Technology

Introduction: Hang Chu, a visionary inventor based in San Mateo, CA, is renowned for his groundbreaking contributions to the world of technology.

Latest Patents: Hang Chu's latest patents include innovative solutions in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Hang Chu has consistently pushed the boundaries of innovation, holding multiple patents that have significantly impacted various industries.

Collaborations: Hang Chu has collaborated with leading tech companies, research institutions, and universities worldwide, fostering a culture of innovation and knowledge-sharing.

Conclusion: Hang Chu's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.